Mygn earnings release
Web13 aug. 2024 · Myriad Genetics (MYGN) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.47 per share. This compares to … WebNAS :MYGN (USA) Portfolio $ 23.19 +0.7 (+3.11%) 10:08 PM EST On watch Warning! GuruFocus detected 2 Severe warning signs with MYGN. Try a 7-Day Free Trial to check it out. Also Trade In: Volume: 398.67K Market Cap $: 1.88B PE Ratio: At Loss Avg Vol (2M): 641.74K Enterprise Value $: 1.91B PB Ratio: 2.13 GF Score: Year: 10Y: -% Above Low: …
Mygn earnings release
Did you know?
WebMyriad Genetics, Inc. — MYGN Q4 2024 Earnings Conference Call. Myriad Genetics, Inc. — MYGN ... the call we will review funny of results we released today and afterwards we … Web13 apr. 2024 · Myriad Genetics, Inc. SEC Filing - Annual Report (10-K) March 01, 2024 SEC FilingsWed, Mar. 01 Myriad Genetics, Inc. (MYGN) Q4 2024 Earnings Call Transcript …
Web1 mrt. 2024 · Myriad Genetics (MYGN) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to loss of $0.02 … Web12 apr. 2024 · SALT LAKE CITY, April 12, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and SimonMed ® Imaging, one of the largest independent outpatient medical imaging providers and physician radiology practices in the United States, today announced the planned launch …
Web2 dagen geleden · Myriad Genetics (MYGN) (Delayed Data from NSDQ) $23.33 USD +0.07 (0.30%) Updated Apr 6, 2024 04:00 PM ET After-Market: $23.32 -0.01 (-0.04%) 7:58 PM … WebFind real-time MYGN - Myriad Genetics Inc stock quotes, company profile, news and forecasts from CNN Business. MYGN - Myriad Genetics Inc Stock quote - CNNMoney.com Markets
Web12 apr. 2024 · SALT LAKE CITY, April 12, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and SimonMed ® Imaging, one of the largest independent outpatient medical imaging providers and physician radiology practices in the United States, today announced the planned launch …
Web10 uur geleden · Analysts had estimated 82.54%, according to Refinitiv IBES data. UnitedHealth raised its adjusted 2024 profit forecast to between $24.50 and $25 per share, compared with its earlier estimate of... maloney\\u0027s eldridgeWeb31 mrt. 2024 · Myriad Genetics, Inc. is estimated to report earnings on 11/01/2024. The upcoming earnings date is derived from an algorithm based on a company's historical … maloney\u0027s dinerWeb20 mrt. 2024 · Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2024. SALT LAKE CITY, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., … maloney\u0027s eldridge iaWebView the 10k annual report for MYGN stock. See latest earnings, revenues, margins, and growth rates. maloney\u0027s downtown tampaWeb30 apr. 2024 · Myriad (MYGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. maloney\\u0027s downtown tampaWebSalt Lake City, UT, February 16, 2010 — Myriad Pharmaceuticals, Inc. (NASDAQ: MYRX) today reported financial results for its second fiscal quarter ended December 31, 2009. “We are pleased with the progress we have made over the past seven months.” said maloney\\u0027s eldridge iaWeb3 feb. 2015 · On 2024-02-28, Myriad Genetics, Inc. (MYGN) announced earnings per share of $-0.20 for the fiscal quarter ending 2024-12-31, beating the average analyst estimate … maloney\\u0027s eldridge iowa